AnalystsInsight

Thomas O'Malley (Barclays): Analyst Track Record and Price‑Target Accuracy

How often Thomas O'Malley’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,562 ratings, compared with the average Wall Street analyst.

3 min readHow we research

Key takeaways

  • Thomas O'Malley ranks #37 of 1,000 analysts in Exent’s scoring (5.0★).
  • 77.3% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 41 days; 69.1% of calls were up 12 months later.
  • Most‑covered stocks: CRDO, AMAT, WDC, NVDA.

Thomas O'Malley’s track record at a glance

Thomas O'Malley of Barclays ranks #37 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on technology. Over a 7‑year lookback, 77.3% of Thomas’s price targets were reached, 24.9 points above the 52.4% average across all analysts.

MetricThomas O'MalleyAll analysts
Price‑target hit rate77.3%52.4%
Median days to hit target41 days91 days
Calls up after 12 months69.1%64.0%
Median 12‑month return of calls+24.8%+13.4%
Hit rate, last 2 years83.3%—
Average worst drop after a call−19.2%—
Ratings in the sample1,562—
Stocks covered37—

How fast price targets were reached

Time to reach the targetThomas O'Malley
Under 30 days43.9%
30–90 days24.2%
90–180 days18.3%
Over 180 days13.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Thomas O'Malley covers most

StockRatings in the sample
CRDO23
AMAT18
WDC18
NVDA17
AMD16
CRUS15
KLAC15
STX15

In the past year Thomas’s ratings were 66% Buy, 31% Hold and 4% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 9, 2026QCOMReiterated: SellSell$180.00
Sep 3, 2026AVGOReiterated: BuyBuy$500.00
Sep 1, 2026NVDAReiterated: BuyBuy$275.00
Sep 1, 2026CRDOReiterated: BuyBuy$300.00
Aug 27, 2026NVDAReiterated: BuyBuy$275.00
Aug 27, 2026MRVLReiterated: BuyBuy$275.00
Aug 20, 2026MRVLReiterated: BuyBuy$275.00
Aug 19, 2026ADIReiterated: BuyBuy$450.00
Aug 14, 2026SNDKReiterated: BuyBuy$2300.00
Aug 13, 2026COHRReiterated: BuyBuy$350.00
Aug 13, 2026CBRSReiterated: BuyBuy$280.00
Aug 13, 2026VECOReiterated: HoldHold$55.00
  • Sep 9, 2026
    Stock
    QCOM
    Action
    Reiterated: Sell
    Rating
    Sell
    Price target
    $180.00
  • Sep 3, 2026
    Stock
    AVGO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $500.00
  • Sep 1, 2026
    Stock
    NVDA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $275.00
  • Sep 1, 2026
    Stock
    CRDO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $300.00
  • Aug 27, 2026
    Stock
    NVDA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $275.00
  • Aug 27, 2026
    Stock
    MRVL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $275.00
  • Aug 20, 2026
    Stock
    MRVL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $275.00
  • Aug 19, 2026
    Stock
    ADI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $450.00
  • Aug 14, 2026
    Stock
    SNDK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $2300.00
  • Aug 13, 2026
    Stock
    COHR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $350.00
  • Aug 13, 2026
    Stock
    CBRS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $280.00
  • Aug 13, 2026
    Stock
    VECO
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $55.00

Live ratings from Thomas O'Malley and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 14, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Thomas O'Malley’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Thomas O'Malley ranks #37 of 1,000 with a 5.0★ rating. 77.3% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 69.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Thomas O'Malley’s success rate is 65.1% by the ranking source and 77.3% by Exent’s price-target hit-rate backtest, with a median of 41 days to reach a target.

Thomas O'Malley (Barclays) covers 37 stocks, mostly in technology. The most frequently rated are CRDO, AMAT, WDC, NVDA, AMD.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.